Dr Hélène Haegel

PhD, Head of Preclinical Biology Department, co-founder

Co-founder of ElsaLys Biotech, Hélène Haegel leads the Preclinical Biology department of the company.

Hélène spent two years at Max-Planck Institut für Immunbiologie in Freiburg (Germany). She then joined the INSERM laboratory, CJF-9403 at the Etablissement Français du Sang (French Blood Service) of Strasbourg. In her previous position Hélène was senior scientist in the Immunopharmacology department and head of the Cellular Immunology laboratory at Transgene. Co-discoverer of Transgene’s anti-CD115, she was also in charge of managing  the preclinical development of this novel therapeutic antibody.


Hélène is PhD in Molecular Biology of the University Louis Pasteur of Strasbourg. She graduated from the Ecole Supérieure de Biotechnologie de Strasbourg.